Injections: IV, IM and SQ |
Rapid onset (IV)
Up to 100% bioavailability
Controlled depot release (IM, SQ)
Suitable for most therapeutic molecules
|
Difficult for patient to self administer (IV)
Patients fear of needles leads to noncompliance
Higher instance of infection
|
|
Vaccines (IM)
Chemotherapy (IV)
Insulin (SQ)
|
42 |
Oral |
|
Poor bioavailability
Overwhelmingly non-targeted
Not viable for larger therapeutics (peptides/proteins)
Potentially inconsistent due to presence of food
|
|
|
54 |
Inhalation |
Direct target to lungs
Fast absorption
|
|
|
|
7 |
Transdermal |
|
Absorption dependent on skin condition and location |
Skin
Systemic (lesser extent)
|
|
4 |